Fierce Healthcare September 18, 2020
The Trump administration has finalized a rule aimed at boosting access to home dialysis and translation for patients with end-stage renal disease.
The Centers for Medicare & Medicaid Services estimates that the End-Stage Renal Disease Treatment Choices Model will save Medicare $23 million over the next five years. The value-based model is designed to incentivize providers to offer home dialysis as an alternative to clinic dialysis.
Providers that participate in the model would have the opportunity to build up their home dialysis capabilities, CMS said.
“All of this matters because you get what you pay for,” Department of Health and Human Services Secretary Alex Azar said on a call with reporters on Friday. “What we’re going to deliver is much...
Today's Sponsors
Today's Sponsor